This page is shared exclusively with GPI clients and prospective partners. Please enter your access code to continue.
Fill in your details and we'll be in touch shortly with your personal access code.
Thanks, we'll review your details and be in touch shortly with your personal access code. Keep an eye on your inbox.
GPI Pulse™ is our subscription-based competitive monitoring and market access platform — bringing pricing, reimbursement, HTA intelligence, and policy tracking across 60+ markets together in one place. With dedicated capabilities for MFN, Globe, and Guard policy analysis, it gives your team the data depth to turn risk into predictable outcomes.
Trusted by leading pharmaceutical companies
Watch our team walk through how GPI Pulse™ works — from the data universe through to pricing, HTA, and reference pricing intelligence. Use the chapter buttons below to jump to the section most relevant to you.
Talk to our team about a GPI Pulse™ subscription — we'll show you exactly what's available for your therapy area, markets, and MFN use case.
Staying on top of competitive activity, pricing changes, HTA decisions, and evolving policy landscapes means manually retrieving information from multiple sources, across different countries, in different languages — then repeating that entire process as markets evolve. It is slow, inconsistent, and impossible to scale.
Fragmented sources across 60+ marketsRelevant data sits across dozens of country-level databases, regulatory bodies, and payer publications — each in a different format, often in a different language.
Constant manual rework as markets evolvePricing decisions, HTA outcomes, and reimbursement status change regularly — meaning any analysis becomes outdated almost immediately without a dedicated process to maintain it.
MFN, Globe & Guard risk caught too lateMFN exposure is created by the launch and pricing decisions you make every day. Without continuous IRP intelligence and launch sequence visibility, teams only see the problem once flexibility is already gone.
Time lost to research instead of strategyWhen teams spend their time pulling data together, they have less capacity for the analysis and decision-making that actually drives competitive advantage.
GPI Pulse™ removes the burden of manual market intelligence. Everything is structured, standardised, and continuously updated — so our clients spend less time retrieving information and more time acting on it.
— GPI Pulse™ product teamA single subscription platform combining 200M+ data points across pricing, reimbursement, and HTA — structured, standardised, continuously updated, and configurable to your organisation's data workflows.
Availability, reimbursement status, and country-specific net pricing across 60+ markets — all in one consistent, source-transparent view. Historical pricing tracks how prices have evolved over time, including relevant analogues, with multi-currency conversion built in. Critical for understanding where MFN-relevant price points are forming across global markets.
60+ pricing marketsGo beyond pack-level pricing with cost-of-treatment data calculated per day, per month, and per annum by country and indication. Gives a representative, comparable view of drug cost across different markets and dosing schedules — without manual calculation — supporting robust policy and access modelling.
60+ pricing marketsStructured HTA data including assessment publications, clinical trial comparators, pricing analogues, payer decisions, and reimbursement timelines — all linked to original source documents. Understand exactly what shaped payer perception in any given market, and track how reimbursement timelines benchmark against your own launch planning.
30+ HTA marketsA comprehensive IRP matrix across 100+ markets detailing referencing rules, matched reference countries, referenced price levels, and policy-specific considerations. Understand how early launch prices enter IRP baskets, predict when they will be picked up by referencing markets, and model alternative launch sequences to reduce MFN, Globe, and Guard exposure before it becomes locked in.
100+ IRP marketsSet up proactive alerts by country, therapy class, indication, or event type — including policy-driven changes such as MFN-related pricing announcements or IRP rule updates — so you are always informed the moment something changes in your space. No relevant development will slip through the net.
60+ marketsVisualise historical launch sequencing and country order trends to inform your own launch strategy. Purpose-built custom reporting templates generate tailored outputs with a click. For teams requiring end-to-end integration, GPI Pulse™ supports configurable data feeds — connecting market intelligence directly into your internal workflows and systems without manual export steps.
60+ marketsUsed across top 10 global pharmaceutical companies and small to mid-sized biotech — by different functions, at every stage of the drug development pipeline.
Stay ahead of competitive activity, track availability and reimbursement status across key markets, and build a clear picture of the landscape before and after launch — without manually chasing data across multiple sources.
Access country-level net pricing, multi-currency comparisons, a full IRP matrix, and pricing analogue data across 60+ markets. Model the reference pricing implications of your launch sequencing decisions and control MFN, Globe, and Guard exposure from Day One — not once it is already embedded.
Use HTA outcomes, reimbursement timelines, and patient copayment data to support trial planning and feasibility assessments — understanding the payer landscape and policy environment before your study design is finalised.
Pricing and reimbursement data across 60+ markets, HTA outcomes across 30+ markets, and IRP reference pricing intelligence across 100+ markets — standardised, translated, and continuously updated across the world's most complex pricing environments.
Markets with pricing & reimbursement data
Markets with HTA assessment data
Markets in IRP reference pricing matrix
Typical support response time
Answers to the questions that come up most in our conversations with market access, pricing, and clinical teams.
Talk to a GPI specialist about what GPI Pulse™ can deliver for your team — including how we support MFN, Globe, and Guard risk management across your portfolio.
GPI Pulse™ — market access intelligence & MFN risk management for global pharma teams.